Safety of NGOIS Compared to BSS Plus in Pediatric Patients

Completed · Phase 3

Conditions studied: Cataract

In brief

To evaluate the Safety of Next Generation Ophthalmic Irrigating Solution compared to BSS Plus for use during cataract surgery in Pediatric patients.

Key facts

Study ID

NCT00346528

Run by

Alcon Research

People needed

18

Starts

2006-07-01

Expected to finish

2007-06-01

Last updated by the study team

2012-03-05

Who can join

Age: 0 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Cataract present.
• Other protocol-defined inclusion criteria may apply.

You may not qualify if…

• As per age requirements.
• Other protocol-defined exclusion criteria may apply.

Where it is running

• Contact Alcon for Trial Locations — Fort Worth, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.